Press releases

PharmaEssentia's third-generation interferon drug candidate P1101 (PEG-P-IFN-alpha-2b) for the treatment of hepatitis B and C, has received US FDA IND approval, with Phase I clinical trials in both Canada and Taiwan set to begin in the third quarter of 20 More

Immunology Laboratories, Inc. was recently granted a patent by the German Patent Office for Compositions and Methods for Treatment of Microbial Infections. More

University of Western Ontario researcher John McCormick has been given a $603,000 boost from the Canadian Institutes of Health Research (CIHR) to investigate how toxic shock syndrome and other severe diseases can be prevented. More

Probiotics research pioneer Gregor Reid will hold the first research chair in Human Microbiology and Probiotics at Lawson Health Research Institute thanks to a $7-million donation from international yogurt maker Danone Group. More

Canada's lacklustre pace in adopting health innovations and commercializing new products and processes is costing our health system, according to organizers of a Richard Ivey School of Business conference taking place next week. More

It appears that some superbugs have evolved to develop the ability to manipulate the immune system to everyone's advantage. More

Geoff Wild of the University of Western Ontario and his fellow researchers developed a formal mathematical model that incorporated theoretical host parasite population dynamics. The model was then run to determine the underlying evolutionary mechanisms of More

Lawson Health Research Institute has released their 2009 overview brochure, "Discovery: Thinking Ahead" More